Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1987 Apr;127(1):27–37.

Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.

K Sheibani, C D Winberg, S van de Velde, D W Blayney, H Rappaport
PMCID: PMC1899594  PMID: 3105322

Abstract

The authors investigated the distribution of interleukin-2 receptors (TAC antigen) in the lymph nodes of 300 patients with lymphoproliferative disorders. They used fresh-frozen sections to evaluate a possible correlation between the immunophenotype of specific lymphoid disorders and the presence or absence of TAC expression and to determine whether the TAC positivity of lymphoid cells contributes to the characterization of lymphoproliferative processes. All of the cases had previously been studied with a large screening panel of monoclonal antibodies and polyclonal antisera. Among 85 patients with a variety of benign reactive processes, the lymph nodes from 47 contained TAC-bearing lymphocytes in various patterns of distribution. Of 41 patients with Hodgkin's disease, 37 had TAC-bearing lymphocytes. Of 26 B-cell, well-differentiated lymphocytic lymphomas (WDL), 14 were diffusely TAC-positive and one had TAC-bearing cells in random distribution. Six cases of intermediate lymphocytic lymphoma were also studied, and three showed randomly distributed TAC-bearing lymphocytes. Of 19 patients with follicular or follicular and diffuse, poorly differentiated lymphocytic (PDL) lymphoma, 14 were TAC-positive. All 3 diffuse PDL lymphomas studied were TAC-negative. Among 23 cases of B-cell and 5 cases of T-cell mixed cell lymphoma, 15 and three, respectively, had TAC-positive lymphocytes. Of 39 large cell lymphomas (B-cell, 33; T-cell, 6), 14 were TAC-positive. All 13 cases of hairy cell leukemia were diffusely positive. Of 23 T-lymphoblastic lymphomas, only 1 showed positive TAC reactivity, which was focal. Of 5 cases of cutaneous T-cell lymphoma, 2 had TAC-bearing lymphocytes. Our study indicates that the TAC antigen is not lineage-specific, and that it may be expressed by lymphoid cells regardless of their phenotype.

Full text

PDF
27

Images in this article

31Figure 1
on p.31
31Figure 2
on p.31
32Figure 3
on p.32
33Figure 4
on p.33
34Figure 5
on p.34
34Figure 6
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd A. W., Fisher D. C., Fox D. A., Schlossman S. F., Nadler L. M. Structural and functional characterization of IL 2 receptors on activated human B cells. J Immunol. 1985 Apr;134(4):2387–2392. [PubMed] [Google Scholar]
  2. Cantrell D. A., Smith K. A. The interleukin-2 T-cell system: a new cell growth model. Science. 1984 Jun 22;224(4655):1312–1316. doi: 10.1126/science.6427923. [DOI] [PubMed] [Google Scholar]
  3. Hofman F. M., Modlin R. L., Bhoopat L., Taylor C. R. Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue. J Immunol. 1985 Jun;134(6):3751–3755. [PubMed] [Google Scholar]
  4. Hsu S. M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981 May;75(5):734–738. doi: 10.1093/ajcp/75.5.734. [DOI] [PubMed] [Google Scholar]
  5. Kishi H., Inui S., Muraguchi A., Hirano T., Yamamura Y., Kishimoto T. Induction of IgG secretion in a human B cell clone with recombinant IL 2. J Immunol. 1985 May;134(5):3104–3107. [PubMed] [Google Scholar]
  6. Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. doi: 10.1073/pnas.80.14.4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Leonard W. J., Depper J. M., Kanehisa M., Krönke M., Peffer N. J., Svetlik P. B., Sullivan M., Greene W. C. Structure of the human interleukin-2 receptor gene. Science. 1985 Nov 8;230(4726):633–639. doi: 10.1126/science.2996141. [DOI] [PubMed] [Google Scholar]
  8. Liebson H. J., Marrack P., Kappler J. B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells. J Immunol. 1982 Oct;129(4):1398–1402. [PubMed] [Google Scholar]
  9. Miyawaki T., Ohzeki S., Ikuta N., Seki H., Taga K., Taniguchi N. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues. J Immunol. 1984 Dec;133(6):2996–3000. [PubMed] [Google Scholar]
  10. Modlin R. L., Hofman F. M., Horwitz D. A., Husmann L. A., Gillis S., Taylor C. R., Rea T. H. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol. 1984 Jun;132(6):3085–3090. [PubMed] [Google Scholar]
  11. Pizzolo G., Chilosi M., Semenzato G., Caligaris-Cappio F., Fiore-Donati L., Perona G., Janossy G. Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer. 1984 Sep;50(3):415–417. doi: 10.1038/bjc.1984.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schmidt R. E., Hercend T., Fox D. A., Bensussan A., Bartley G., Daley J. F., Schlossman S. F., Reinherz E. L., Ritz J. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol. 1985 Jul;135(1):672–678. [PubMed] [Google Scholar]
  13. Shamoto M., Suchi T., Uchiyama T. Immunoelectron-microscopic localization of Tac antigen in adult T-cell leukemia/lymphoma. Am J Pathol. 1985 Jun;119(3):513–516. [PMC free article] [PubMed] [Google Scholar]
  14. Shaw A. R., Bleackley R. C., Merryweather J. P., Barr P. J. Modulation of human natural killer cell activity by recombinant human interleukin 2. Cell Immunol. 1985 Feb;90(2):547–554. doi: 10.1016/0008-8749(85)90219-9. [DOI] [PubMed] [Google Scholar]
  15. Sheibani K., Tubbs R. R. Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol. 1984 Nov;1(4):235–250. [PubMed] [Google Scholar]
  16. Suzuki T., Cooper M. D. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody. J Immunol. 1985 May;134(5):3111–3119. [PubMed] [Google Scholar]
  17. Touw I., Delwel R., Bolhuis R., van Zanen G., Löwenberg B. Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation. Blood. 1985 Sep;66(3):556–561. [PubMed] [Google Scholar]
  18. Uchiyama T., Nelson D. L., Fleisher T. A., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol. 1981 Apr;126(4):1398–1403. [PubMed] [Google Scholar]
  19. Waldmann T. A., Goldman C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Korsmeyer S. J., Greene W. C. Expression of interleukin 2 receptors on activated human B cells. J Exp Med. 1984 Nov 1;160(5):1450–1466. doi: 10.1084/jem.160.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]
  21. Zubler R. H., Lowenthal J. W., Erard F., Hashimoto N., Devos R., MacDonald H. R. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med. 1984 Oct 1;160(4):1170–1183. doi: 10.1084/jem.160.4.1170. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES